
Revvity to Showcase Strategy at 2026 Investor Day
Revvity, Inc. announced its 2026 Investor Day on November 13, where management will provide updates on key business initiatives, operational achievements, and financial outlook under the theme 'Powering Scientific Intelligence'. The company will highlight its differentiated portfolio in Life Sciences and Diagnostics, emphasizing its position at the intersection of biology, experimentation, and data to support AI-enabled discovery workflows. Revvity aims to demonstrate its strong position for above-market growth and sustained shareholder value, outlining strategic priorities and a long-range financial outlook. The company projects 2026E revenue of approximately $2.9 billion, with significant growth expected in its Signals Software segment.
Key Highlights
- Revvity to host Investor Day 2026 on November 13, showcasing strategy for 'Powering Scientific Intelligence'.
- Company to highlight differentiated portfolio in Life Sciences and Diagnostics, connecting biology, data, and AI.
- Revvity aims to demonstrate strong position for above-market growth and sustained shareholder value.
- CEO Prahlad Singh to outline strategic priorities, operational initiatives, and long-range financial outlook.
- Key focus areas include differentiated portfolio, future of scientific discovery, and long-term value creation.
- 2026E Revenue projected at ~$2.9B, with ~55% from Life Sciences and ~45% from Diagnostics.
- Signals Software segment projected to grow at 40% CAGR, with ARR over $275M by 2026E.
- Life Sciences Solutions segment projected to grow at 6-8% LRP organic growth.
Price Impact
More from RVTY